Hang Seng Indexes Company (Hang Seng Indexes) has launched the Hang Seng SCHK Mainland China Healthcare Index (HSSCHI).
The HSSCHI reflects the performance of mainland China companies in the healthcare sector that are listed in Hong Kong and are eligible for trading via the southbound trading link of the Stock Connect Scheme. Such companies are defined as Hong Kong-listed companies with at least 50 per cent of their sales revenue (or profits or assets if relevant) derived from the Mainland. Companies in the healthcare sector include companies working in areas of medical devices, pharmaceuticals, biotechnology, and medical & aesthetic services.
Daniel Wong, Director & Head of Research and Analytics at Hang Seng Indexes, says: “We have observed increasing market interest in healthcare as an investment theme. This index aims to meet the needs of product issuers looking to create funds that provide exposure to this sector of the Hong Kong stock market.”
The index is calculated and disseminated real-time at two-second intervals.
